Impact of antiphospholipid and antinuclear antibodies in coronary artery disease progression
Background/ObjectivesThe role of antiphospholipid (aPL) and antinuclear antibodies (ANA) in the progression of coronary artery disease (CAD) remains uncertain. We aimed to determine whether the presence of aPL or ANA predicts CAD progression.MethodsWe …